Purdue Asthma Test Helps Heal Racehorses

Indiana is the only place in the world with a cutting-edge respiratory testing device for horses. Veterinarians and engineers at the Purdue University College of Veterinary Medicine developed the tool to bring clarity to an elusive condition. Behind lameness, respiratory issues are the second-leading cause of an equine athlete’s poor performance, but symptoms are subtle and difficult to spot. The technology is providing answers for owners who begin to question why their horse is slowing down.

Purdue says Indiana’s equine industry is an important piece of the state’s economy, generating about $2 billion annually. Indiana is home to 160,000 equine, valued at more than $795 million, so keeping horses—especially elite athletes—in peak performance condition is a top priority.

Read more at Purdue Asthma Test Helps Heal Racehorses from Inside Indiana Business.

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

Today we are highlighting Rebecca Hoffman, BS, RVT, who is a veterinary technologist with the Bovine Field Service.

Learning Specialist Joins PVM Student Success Center Team

Purdue Veterinary Medicine’s Student Success Center is pleased to welcome Kelsey Luse Spille, who joined the team Monday, November 4, as a learning specialist.  In her new role, she will be supporting students with their academic needs while also serving as a member of the Veterinary Education Support Team (VEST), which assists faculty in developing inclusive teaching practices.

Purdue College of Veterinary Medicine Hosts Reception to Welcome New Dean Bret Marsh

Faculty, staff and students gathered at a reception in the Veterinary Medical Library Friday, November 8, to help extend a warm welcome the new dean of the Purdue University College of Veterinary Medicine, Dr. Bret Marsh.  The event marked the conclusion of the first week on the job for Dr. Marsh, who just started in the role Monday, November 4, after wrapping-up 30 years of service as Indiana State Veterinarian – the state’s top-ranking animal health leader.

Awareness Week to Shine Spotlight on Antimicrobial Resistance Next Week

Antimicrobial resistance (AMR) is a growing, significant One Health issue across the world. The WHO estimates that AMR was directly responsible for 1.27 million global deaths and contributed to 4.95 million deaths, with additional significant economic costs. AMR affects all countries and all income groups, and to tackle this urgent problem, researchers, producers, and practitioners from all areas must address the critical shortage of new antimicrobial drugs, and the use of antimicrobial drugs in medicine, farming, and industry. The week of November 18-24 is US Antibiotic Awareness Week and World AMR Awareness Week, and the College of Veterinary Medicine is taking advantage of these national and global campaigns to raise awareness about AMR and antimicrobial stewardship, and to highlight some of the research and practices being conducted at the college to address AMR.

PVM Faculty Honored for Research Success with Purdue Seed for Success Acorn Awards

When Purdue University’s Office of Research honored the accomplishments and innovative ideas of a host of researchers this week, several Purdue Veterinary Medicine scholars were among those recognized. At a ceremony Wednesday, November 14, in the Purdue Memorial Union North and South Ballrooms, the annual Seed for Success Acorn Awards were presented to Purdue Principal Investigators (PIs) and co-PIs who secured research awards of $1 million or more for a single proposal in fiscal year 2024.

Unlocking the Mysteries of the Brain

Despite more than six decades of research in the field of neuroscience, many functions of the brain — the most complex organ in the human body — remain a mystery. Recent research conducted in the Purdue University College of Veterinary Medicine and the Bindley Bioscience Center revealed that scientists are one step closer to understanding the process that activates and deactivates specific proteins within our cells. This breakthrough could one day lead to enhanced treatments that may slow down or perhaps reverse the advance of neurogenerative diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis.